Amplified Attention Training (AAT) for Age-related Cognitive Decline

DESCRIPTION provided by applicant The goal of the current project is to revise a prototype of a computerized attention training program Memory Lane Amplified Attention Training M AAT designed for age related cognitive decline completed in Phase I and conduct a multi site randomized controlled trial to establish efficacy in this population As a group individuals with age related cognitive decline tend to have poorer long term prognosis and are more likely to require managed care than individuals without similar declines Our recent studies are among the first to demonstrate that M AAT targeting sustained attention and cognitive control can produce lasting benefits The overall goal of the current project is to measure co primary outcomes attention executive function and functional capacity Evidence from our Phase I trial shows that M AAT can improve attention and executive function At the completion of this project we will have outcomes data sufficient for submission to the FDA for clearance as a medical device indicated for cognitive enhancement in age related cognitive decline ICD Code R PUBLIC HEALTH RELEVANCE The goal of this project is to revise a prototype of a computerized cognitive training program Memory Lane Amplified Attention Training M AAT for individual with age related cognitive decline completed in Phase I and conducts a multi site randomized controlled trial to demonstrate efficacy This is important because this large population suffers from poor prognosis and a lack of viable treatment options